Succeeding in the 2020 Global Infectious Disease Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

Succeeding in the 2020 Global Infectious Disease Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • February 2020 •
  • 1900 pages •
  • Report ID: 5861717 •
  • Format: PDF
Succeeding in the 2020 Global Infectious Disease Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

This new report is a seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, market segment, and country; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Companies Profiled
Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako